| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sarepta Therapeutics, Inc. (SRPT) has 14 insiders with recent SEC Form 4 filings, including 9 buys and 5 sells. SRPT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 2.98M | $52.66M | - | |
| CEO | 490.3K | $8.65M | - | |
| Pres | 227.2K | $4.01M | - | |
| Dir | 214.4K | $3.78M | - | |
| COO | 202.0K | $3.56M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 22, 2019 | Howton David T | EVP, General Counsel | Sale+OE | 25,000 | $105.00 | $2,625,000.00 | -35.4% | |
| Sep 13, 2019 | Barry Richard70 | Director | Buy | 5,000 | $87.49 | $437,454.90 | - | |
| Sep 9, 2019 | Bonney Michael W | Director | Buy | 2,000 | $86.74 | $173,480.00 | +39.6% | |
| Sep 6, 2019 | Behrens M Kathleen | Director | Buy | 2,500 | $87.98 | $219,950.00 | +2.0% | |
| Aug 20, 2019 | Barry Richard70 | Director | Buy | 5,000 | $99.32 | $496,592.50 | +0.2% | |
| Aug 14, 2019 | Barry Richard70 | Director | Buy | 3,700 | $122.50 | $453,250.00 | +0.1% | |
| Aug 12, 2019 | Barry Richard70 | Director | Buy | 1,300 | $122.50 | $159,250.00 | - | |
| Aug 12, 2019 | Ingram Douglas S | President &CEO | Buy | 16,252 | $123.07 | $2,000,160.32 | +1.9% | |
| May 23, 2019 | Wigzell Hans Lennart Rudolf60 | Director | Sale+OE | 10,000 | $120.00 | $1,200,000.00 | -46.0% | |
| Feb 7, 2019 | Mahatme Sandesh | EVP, CFO &Cbo | Sale+OE | 65,000 | $145.00 | $9,425,000.00 | -88.3% |